top of page

News & Updates

Filter by:

Why Dr Eric Topol Calls CHIP a Primary Cardiovascular Risk Driver

News & Updates

Mar 18, 2026

Why Dr Eric Topol Calls CHIP a Primary Cardiovascular Risk Driver

Read More
Why Dr Eric Topol Calls CHIP a Primary Cardiovascular Risk Driver
Lucence, DxD Hub and NCCS Launch S$6M Research Collaboration to Advance Cancer Diagnostics Through AI and Patient-Centric Research

News & Updates

Mar 13, 2026

Lucence, DxD Hub and NCCS Launch S$6M Research Collaboration to Advance Cancer Diagnostics Through AI and Patient-Centric Research

Read More
Lucence, DxD Hub and NCCS Launch S$6M Research Collaboration to Advance Cancer Diagnostics Through AI and Patient-Centric Research
Lucence and Partners Pathology Collaborate to Advance Cancer Diagnostics in Malaysia

News & Updates

Mar 5, 2026

Lucence and Partners Pathology Collaborate to Advance Cancer Diagnostics in Malaysia

Read More
Lucence and Partners Pathology Collaborate to Advance Cancer Diagnostics in Malaysia
Lucence CEO Dr. Tan Min-Han Featured in The Straits Times: The Future of Precision Health and Longevity

News & Updates

Jan 28, 2026

Lucence CEO Dr. Tan Min-Han Featured in The Straits Times: The Future of Precision Health and Longevity

Read More
Lucence CEO Dr. Tan Min-Han Featured in The Straits Times: The Future of Precision Health and Longevity
Lucence Launches CardioHemeRISK™ in the U.S. to Identify Early Risk Markers Associated with Heart Attack, Stroke, and Leukemia

News & Updates

Jan 12, 2026

Lucence Launches CardioHemeRISK™ in the U.S. to Identify Early Risk Markers Associated with Heart Attack, Stroke, and Leukemia

Read More
Lucence Launches CardioHemeRISK™ in the U.S. to Identify Early Risk Markers Associated with Heart Attack, Stroke, and Leukemia
Lucence Demonstrates Combined ctDNA and ctRNA Liquid Biopsy Improves Diagnostic Yield at ASCO 2025

News & Updates

May 30, 2025

Lucence Demonstrates Combined ctDNA and ctRNA Liquid Biopsy Improves Diagnostic Yield at ASCO 2025

Read More
Lucence Demonstrates Combined ctDNA and ctRNA Liquid Biopsy Improves Diagnostic Yield at ASCO 2025
Agilus Diagnostics and Lucence Announce Strategic Collaboration to Advance Cancer Testing Services in India

News & Updates

Feb 24, 2025

Agilus Diagnostics and Lucence Announce Strategic Collaboration to Advance Cancer Testing Services in India

Read More
Agilus Diagnostics and Lucence Announce Strategic Collaboration to Advance Cancer Testing Services in India
Mayo Clinic Laboratories and Lucence announce strategic collaboration to enhance cancer testing services

News & Updates

Jan 10, 2025

Mayo Clinic Laboratories and Lucence announce strategic collaboration to enhance cancer testing services

Read More
Mayo Clinic Laboratories and Lucence announce strategic collaboration to enhance cancer testing services
Lucence Secures MolDX Approval for LiquidHALLMARK® ctDNA and ctRNA Liquid Biopsy Test to Advance Non-Invasive Cancer Diagnostics

News & Updates

Jan 2, 2025

Lucence Secures MolDX Approval for LiquidHALLMARK® ctDNA and ctRNA Liquid Biopsy Test to Advance Non-Invasive Cancer Diagnostics

Read More
Lucence Secures MolDX Approval for LiquidHALLMARK® ctDNA and ctRNA Liquid Biopsy Test to Advance Non-Invasive Cancer Diagnostics

1

/

5

bottom of page